LETTER
Efficient Palladium-Catalyzed Synthesis of Unsymmetrical (Het)aryltetrazines
209
(18) Palladium-Catalyzed Cross-Coupling Reaction of
Compound 1 with Boronic Acids 2a–i; General
3-(Morpholin-4-yl)-6-(4-acetylphenyl)-1,2,4,5-tetrazine
(3e): 4-Acetylphenylboronic acid(2e) was used as the
boronic acid derivative; yield: 54%; red solid; mp 194–197
°C. MS (Ionspray®): m/z = 286 [M + H]+. 1H NMR (250
MHz, CDCl3): d = 8.49 (d, J = 8.8 Hz, 2 H), 8.11 (d, J = 8.8
Hz, 2 H), 4.09 (t, J = 4.6 Hz, 4 H), 3.89 (t, J = 4.6 Hz, 4 H),
2.41 (s, 3 H). 13C NMR (62.5 MHz, CDCl3): d = 197.7 (C),
160.2 (C), 158.7 (C), 138.6 (C), 136.9 (C), 129.1 (CH),
126.4 (CH), 66.6 (CH2), 43.9 (CH2), 26.9 (CH3). IR: 2975,
2874, 2324, 1676, 1536, 1269, 1114, 943, 849 cm–1. HRMS:
m/z [M+·] calcd for C14H15N5O2: 285.1226; found: 285.1216.
3-(Morpholin-4-yl)-6-(3-cyanophenyl)-1,2,4,5-tetrazine
(3f): 3-Cyanophenylboronic acid (2f) was used as the
boronic acid derivative; yield: 28%; red solid; mp 197–198
°C. MS (Ionspray®): m/z = 269 [M + H]+. 1H NMR (250
MHz, CDCl3): d = 8.71 (dt, J = 0.5, 1.5 Hz, 1 H), 8.63 (dt,
J = 1.5, 8.0 Hz, 1 H), 7.79 (dt, J = 1.5, 8.0 Hz, 1 H), 7.65 (dt,
J = 0.5, 8.0 Hz, 1 H), 4.09 (t, J = 4.7 Hz, 4 H), 3.89 (t, J = 4.7
Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): d = 160.4 (C), 157.8
(C), 134.1 (C), 133.8 (CH), 130.1 (CH), 130.0 (CH), 129.8
(CH), 118.5 (C), 113.5 (C), 66.5 (CH2), 43.9 (CH2). IR:
2872, 2235, 1536, 1446, 1255, 1117, 1034, 966 cm–1.
HRMS: m/z [M+·] calcd for C13H12N6O: 268.1073; found:
268.1079.
Procedure: 3-Methylthio-6-(morpholin-4-yl)-1,2,4,5-
tetrazine (1; 100 mg, 0.5 mmol), boronic acid (1.1 mmol)
and CuTC (197 mg, 1.1 mmol) were dissolved in anhyd
DME (5 mL) in a sealed reaction vessel under argon. After
the mixture was degassed, Pd(PPh3)4 (27 mg, 0.025 mmol)
was added and the reaction mixture was stirred under
microwave irradiation at 200 °C (14–16 bars) for 2 h. The
reaction mixture was then allowed to cool to r.t., poured into
sat. aq Na2CO3 and extracted with CH2Cl2. The organic
phases were collected, dried over MgSO4 and the solvent
was removed under reduced pressure. Desired compounds
were purified by chromatography on silica gel (PE–EtOAc =
95:5 to 7:3).
3-(Morpholin-4-yl)-6-(4-methoxyphenyl)-1,2,4,5-
tetrazine (3a): 4-Methoxyphenylboronic acid (2a; yield:
71%) and 1-methoxy-4-tributylstannylbenzene (4a; yield:
49%) were used as the boronic acid and the organostannane
derivatives, respectively; red solid; mp 176–178 °C. MS
(Ionspray®): m/z = 274 [M + H]+. 1H NMR (250 MHz,
CDCl3): d = 8.34 (d, J = 9.0 Hz, 2 H), 7.05 (d, J = 9.0 Hz, 2
H), 4.04 (t, J = 4.5 Hz, 4 H), 3.89 (s, 3 H), 3.87 (t, J = 4.5 Hz,
4 H). 13C NMR (62.5 MHz, CDCl3): d = 162.0 (C), 160.6
(C), 159.5 (C), 128.0 (CH), 125.3 (C), 114.6 (CH), 66.6
(CH2), 55.6 (CH3), 43.9 (CH2). IR: 2917, 1607, 1512, 1438,
1244, 1116, 1034, 936, 837 cm–1. Anal. Calcd for
3-(Morpholin-4-yl)-6-(3-trifluoromethylphenyl)-1,2,4,5-
tetrazine (3g): 3-Trifluoromethylphenylboronic acid (2g)
was used as the boronic acid derivative; yield: 31%; red
solid; mp 144 °C. MS (Ionspray®): m/z = 311.5 [M + H]+. 1H
NMR (250 MHz, CDCl3): d = 8.69 (s, 1 H), 8.58 (d, J = 7.8
Hz, 1 H), 7.76 (d, J = 7.8 Hz, 1 H), 7.66 (t, J = 7.8 Hz, 1 H),
4.08 (t, J = 4.5 Hz, 4 H), 3.89 (t, J = 4.5 Hz, 4 H). 13C NMR
(62.5 MHz, CDCl3): d = 160.5 (C), 158.4 (C), 133.6 (C),
131.6 (2JC–F = 33 Hz, C), 129.7 (CH), 129.3 (CH), 127.3
C13H15N6O2 (273): C, 57.13; H, 5.53; N, 25.63. Found: C,
57.34; H, 5.52; N, 24.48.
3-(Morpholin-4-yl)-6-(3-methoxyphenyl)-1,2,4,5-
tetrazine (3b): 3-Methoxyphenylboronic acid (2b) was used
as the boronic acid derivative; yield: 67%; red solid; mp
140–142 °C. MS (Ionspray®): m/z = 274 [M + H]+. 1H NMR
(250 MHz, CDCl3): d = 7.99 (dt, J = 1.0, 8.0 Hz, 1 H), 7.93
(dd, J = 1.0, 2.6 Hz, 1 H), 7.43 (t, J = 8.0 Hz, 1 H), 7.05 (ddd,
J = 1.0, 2.6, 8.0 Hz, 1 H), 4.05 (t, J = 4.5 Hz, 4 H), 3.89 (s, 3
H), 3.87 (t, J = 4.5 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3):
d = 160.5 (C), 160.2 (C), 159.3 (C), 134.0 (C), 130.1 (CH),
118.8 (CH), 117.4 (CH), 110.7 (CH), 66.5 (CH2), 55.5
(CH3), 43.8 (CH2). IR: 2927, 2857, 1598, 1522, 1448, 1262,
1229, 1119, 963, 786 cm–1. HRMS: m/z [M+·] calcd for
C13H15N5O2: 273.1226; found: 273.1220.
(3JC–F = 4 Hz, CH), 124.1 (1JC–F = 271 Hz, C), 123.2 (3JC–F
4 Hz, CH), 66.5 (CH2), 43.9 (CH2). IR: 2917, 2850, 1530,
1446, 1302, 1268, 1166, 1120, 1066, 1034, 963, 945, 695
=
cm–1. HRMS: m/z [M+·] calcd for C13H12N5OF3: 311.0994;
found: 311.0991.
3-(Morpholin-4-yl)-6-(3-bromophenyl)-1,2,4,5-tetrazine
(3h): 3-Bromophenylboronic acid (2h) was used as the
boronic acid derivative; yield: 42%; red solid; mp 141–142
°C. 1H NMR (250 MHz, CDCl3): d = 8.56 (t, J = 1.5 Hz, 1
H), 8.33 (ddd, J = 1.0, 1.5, 8.0 Hz, 1 H), 7.64 (ddd, J = 1.0,
1.5, 8.0 Hz, 1 H), 7.40 (t, J = 8.0 Hz, 1 H), 4.07 (t, J = 4.4
Hz, 4 H), 3.88 (t, J = 4.4 Hz, 4 H). 13C NMR (62.5 MHz,
CDCl3): d = 160.5 (C), 158.4 (C), 134.8 (C), 133.7 (CH),
130.6 (CH), 129.4 (CH), 124.8 (CH), 123.4 (C), 66.6 (CH2),
43.9 (CH2). IR: 2361, 2337, 1530, 1447, 1254, 1123, 1031,
944, 780, 733 cm–1. HRMS: m/z [M+·] calcd for
3-(Morpholin-4-yl)-6-(3-methylphenyl)-1,2,4,5-tetrazine
(3c): 3-Methylphenylboronic acid (2c) was used as the
boronic acid derivative; yield 58%; red solid; mp 127–129
°C. MS (Ionspray®): m/z = 258.5 [M + H]+. 1H NMR (250
MHz, CDCl3): d = 8.22 (s, 1 H), 8.20 (d, J = 7.8 Hz, 1 H),
7.42 (t, J = 7.8 Hz, 1 H), 7.33 (d, J = 7.8 Hz, 1 H), 4.06 (t,
J = 4.7 Hz, 4 H), 3.88 (t, J = 4.7 Hz, 4 H), 2.46 (s, 3 H). 13
C
NMR (62.5 MHz, CDCl3): d = 160.6 (C), 159.7 (C), 139.9
(C), 132.6 (C), 131.6 (CH), 129.1 (CH), 127.1 (CH), 123.6
(CH), 66.6 (CH2), 43.9 (CH2), 21.7 (CH3). IR: 2965, 2860,
2362, 2338, 1521, 1451, 1252, 1116, 941, 784 cm–1. HRMS:
m/z [M+·] calcd for C13H15N5O: 257.1277; found: 257.1288.
3-(Morpholin-4-yl)-6-(3-acetylphenyl)-1,2,4,5-tetrazine
(3d): 3-Acetylphenylboronic acid (2d) was used as the
boronic acid derivative; yield: 56%; red solid; mp 174–176
°C. MS (Ionspray®): m/z = 286 [M + H]+. 1H NMR (250
MHz, CDCl3): d = 8.98 (s, 1 H), 8.60 (d, J = 7.9 Hz, 1 H),
8.12 (d, J = 7.9 Hz, 1 H), 7.65 (t, J = 7.9 Hz, 1 H), 4.09 (t,
C12H12N5O79Br: 321.0225; found: 321.0211.
3-(Morpholin-4-yl)-6-(naphtalen-2-yl)-1,2,4,5-tetrazine
(3i): Naphthalen-2-ylboronic acid (2i) was used as boronic
acid derivative; yield: 60%; red solid; mp 172–173 °C. MS
(Ionspray®): m/z = 294 [M + H]+. 1H NMR (250 MHz,
CDCl3): d = 8.93 (s, 1 H), 8.48 (dd, J = 1.8, 8.5 Hz, 1 H), 7.99
(d, J = 8.5 Hz, 2 H), 7.89 (t, J = 5.0 Hz, 1 H), 7.54 (m, 2 H),
4.08 (t, J = 4.5 Hz, 4 H), 3.89 (t, J = 4.5 Hz, 4 H). 13C NMR
(62.5 MHz, CDCl3): d = 160.5 (C), 159.7 (C), 134.7 (C),
133.5 (C), 130.0 (C), 129.2 (CH), 129.0 (CH), 128.0 (CH),
127.4 (CH), 126.8 (CH), 126.5 (CH), 123.3 (CH), 66.6
(CH2), 43.9 (CH2). IR: 2960, 2869, 2359, 1522, 1451, 1336,
1262, 1119, 953 cm–1. Anal. Calcd for C16H15N5O(293): C,
65.52; H, 5.15; N, 23.88. Found: C, 65.64; H, 5.07; N, 23.26.
(19) Cross-Coupling Reaction Followed by an Oxidative
Treatment (Compounds 3g–j): Same procedure as in ref.
18 was used with an extra oxidative step, described as
follows. The crude product was dissolved in CH2Cl2. After
J = 4.4 Hz, 4 H), 3.89 (t, J = 4.4 Hz, 4 H), 2.70 (s, 3 H). 13
C
NMR (62.5 MHz, CDCl3): d = 197.7 (C), 160.5 (C), 158.7
(C), 137.9 (C), 133.2 (C), 130.5 (CH), 130.1 (CH), 129.5
(CH), 126.4 (CH), 66.5 (CH2), 43.8 (CH2), 26.9 (CH3). IR:
2981, 2906, 2359, 2340, 1692, 1536, 1262, 1111, 967, 946
cm–1. HRMS: m/z [M+·] calcd for C14H15N5O2: 285.1226;
found: 285.1213.
Synlett 2007, No. 2, 204–210 © Thieme Stuttgart · New York